Join us for an overview of TransCelerate’s Pharmacovigilance Agreements Optimization (PVAO) Initiative, which includes a suite of solutions designed to help organizations enhance their PVA process. These solutions can help organizations improve their processes and potentially achieve more efficient negotiations with business partners globally.
The webinar will include:
- An overview of the Pharmacovigilance Agreements Optimization (PVAO) Initiative that could be used to inform and/or help streamline the end-to end PVA process.
- A deeper dive into the two most recent solutions:
- Timelines Benchmarking: Aggregate benchmarking data on exchange timelines.
- Audit Process Efficiencies: Suite of solutions providing marketing partner audit considerations.
- Q&A will address audience questions on the PVAO solution.
Panelists:
- Yvonne Gibble, Executive Director, Pharmacovigilance Partner Strategy & Management, Merck Sharpe & Dohme, LLC
- Beth MacEntee Pileggi, Senior Director, Safety Information Management & Automation, Johnson & Johnson
- Wendy Manko Singer, Associate Vice President, Individual Case Medical Review, Global Clinical Safety & Pharmacovigilance, Merck Sharpe & Dohme, LLC
- Jonathan Rowell, Senior Director, Head of Pharmacovigilance QA, Johnson & Johnson
Ideal Attendees:
- Alliance Managers
- Safety Scientists
- Pharmacovigilance Managers, Officers, Associates, Specialists, Directors,
- Pharmacovigilance Licensing, Experts, Leads.
- Safety Data Exchange Agreement Managers, Officers, Associates, Specialists, Directors,
- Patient Safety Directors, Managers, Officers, Associates, Specialists,
- Global and Local Patient Safety, Pharmacovigilance Country Head(s), QPPV, Local QPPV
- Business Development and Licensing (BD&L) Directors, Associate Directors, Managers
TransCelerate webinars may be recorded in whole or in part.